Le Lézard
Classified in: Health
Subject: MISCELLANEOUS

With 48% of pregnancies being unintentional, let's talk about contraception options


OTTAWA, Ontario, Sept. 24, 2022 (GLOBE NEWSWIRE) -- As Monday September 26 is World Contraception Day, the SOGC wishes to bring your focus on issues still not solved in Canada. Statistics shows that 48% of young women unintentionally become pregnant (1). This means too few women and girls do not know enough about the options available. Policymakers, educators, corporations and even medical professionals must do more to help.

First option: education. We are offering a podcast to help women and young women to learn about contraception options available and how to discuss the matter with a physician. A panel of experts was gathered by The Brand is Female on Apple Podcasts or Spotify (free recording available on Monday). The Brand is Female is Canada's leading podcast about women leadership. For World Contraception Day, the SOGC also came up with a specific set of solutions gathered in one location: www.sogc.org/contraception. The SOGC also offers reliable and trustworthy online tools ? pregnancyinfo.ca, itsaplan.ca ? and a partner such as Organon offers essencelle.ca. They provide women, particularly those in vulnerable positions, with vital information to become their own advocates.

Second option: availability. Abortion pill is unequally available throughout Canada, for example rarely proposed in Atlantic Provinces and Quebec, and rarely available without prescription. The SOGC is totally in favor of health solutions, including contraceptives, being easier to get for women and girls Canada-wide. In many places, barriers will have to burst through or worked around.

Third: time for men to do more. Men must educate themselves on contraception issues and become responsible sexual partners. And where they hold positions of decision-making and sway, men must champion progress and push for positive change.

On this September 26th, World Contraception Day is an opportunity to recognize that millions of women and girls need more education, better availability for contraception options, and better cooperation from men. The SOGC's latest podcast hopes to help these women to learn and discuss contraception more openly with their partner or with their doctor.

(1) Organon Canada Ipsos Survey Results, March 2022.

Podcast Preview:

https://drive.google.com/file/d/1tI9dRIwHru9-nLLr7xI_os_tv3CQ9CV7/view?usp=sharing

episode part 2: https://drive.google.com/file/d/1hqJhTBe6ktUP0-7Gs3Upyk9xg7Nx6i9k/view?usp=sharing

Source: Society of Obstetricians and Gynecologists of Canada
1-800-561-2416 ext. 232 or [email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/88e321ce-03c9-4f16-9b0a-74d4f8521d4a



These press releases may also interest you

at 09:10
BioSkryb Genomics, a company ushering in the next generation of single-cell technology, will highlight how its ResolveDNA and ResolveOME single-cell assays can unravel the complexities of tumor evolution at the American Association for Cancer...

at 09:07
KURU® Footwear, the inventor of heel-first footwear, today unveiled its 2024 Foot Pain Trends Report. Featuring significant industry discoveries and valuable consumer perspectives, KURU's comprehensive and medically reviewed report highlights the...

at 09:05
Personalis, Inc. , a leader in advanced genomics for precision oncology, announced today that a podium talk and multiple abstracts featuring data for the company's NeXT Personal® whole genome-based, tumor-informed assay for ultra-sensitive ctDNA...

at 09:05
...

at 09:04
Canadian-based Noze, a global leader in the breath-based diagnostic space, announced today it received a new grant from the Bill & Melinda Gates Foundation, bringing the foundation's total grant funding to Noze to $1.8 million. The announcement comes...

at 09:00
Headlands Research, a leading multinational network of clinical trial sites, today announced a fifth site, Headlands Research Orlando, as part of its partnership with Pfizer to create multiple clinical trial sites in areas with highly diverse...



News published on and distributed by: